Table 1 Study patient characteristics
From: Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
Total number of patients | 44 |
|---|---|
Demographic | |
 Age, year, median (IQR) | 63.5 (58.0–68.5) |
 Male, n (%) | 18 (40.9) |
Comorbidities | |
 Body mass index, kg/m2, median (IQR) | 34.7 (32.0–41.8) |
 Current smoking, n (%) | 3 (6.8%) |
 Type 2 diabetes, n (%) | 19 (43.2%) |
 Insulin use, n (%) | 6 (13.6%) |
 MI, n (%) | 5 (11.4%) |
 Statin use, n (%) | 33 (75.0%) |
 Family history of MI, n (%) | 22 (50.0%) |
 10-year Reynolds risk score, %, median (IQR) | 11.2 (4.2–19.4) |
Laboratory data, median (IQR) | |
 Uric acid, mg/dL | 7.8 (7.1–8.4) |
 Total cholesterol, mg/dL | 167.5 (153.0–198.0) |
 Triglycerides, mg/dL | 172.5 (115.0–201.5) |
 HDL, mg/dL | 44.0 (38.0–54.0) |
 LDL, mg/dL | 87.0 (76.5–116.5) |
 Fasting blood glucose, mg/dL | 100.5 (92.5–135.0) |
 Serum creatinine, mg/dL | 0.9 (0.8–1.2) |
 eGFR, mL/min/1.73m2 | 48.5 (34.5–57.5) |
 Fasting insulin, mIU/L | 18.2 (14.4–21.9) |
 HOMA-IR | 4.8 (3.4–6.5) |
 hs-CRP, mg/L | 2.9 (1.1–7.4) |
 Interleukin-6, pg/mL | 4.5 (2.4–6.8) |
 Urine microalbumin, mg/L | 15.0 (7.5–43.4) |
Cardiovascular function, median (IQR) | |
 Systolic blood pressure, mmHg | 131 (123–146) |
 Diastolic blood pressure, mmHg | 65 (61–76) |
 Rest heart rate, per minute | 72 (64–78) |
 Stress heart rate, per minute | 94 (84–103) |
 Rest myocardial blood flow, mL/min/g | 0.8 (0.7–0.9) |
 Stress myocardial blood flow, mL/min/g | 1.7 (1.3–2.2) |
 Coronary flow reserve | 1.9 (1.7–2.4) |
 Rest left ventricular ejection fraction, % | 60.0 (52.0–67.0) |
 Stress left ventricular ejection fraction, % | 63.0 (54.5–70.0) |
 Summed stress score | 0 (0–6) |
 Summed rest score | 0 (0–0) |
 Summed difference score | 0 (0–5) |